Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Colonic Neoplasms × Panitumumab × Clear all

Phase

Phase 2 15 Phase 3 4 Phase 1/2 4 Phase 1 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Neoplasm Metastasis 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Propofol 3 Morphine 3 Fentanyl 3 Sevoflurane 2 Ropivacaine 2 Oxaliplatin 2 Bevacizumab 2 Acetaminophen 2 polyethylene glycol 3350 1 oxycodone-acetaminophen 1 gatorade 1 fish oil triglycerides 1 Vitamin D 1 Tranexamic Acid 1 Tramadol 1 Sodium Chloride 1 Simethicone 1 Saline Solution 1 Rivaroxaban 1 Polyethylene Glycols 1 Pirinitramide 1 Panitumumab 1 Orphenadrine 1 Neuroleptanalgesia 1 Midazolam 1 Methadone 1 Magnesium Oxide 1 Lidocaine 1 Ketorolac Tromethamine 1 Ketorolac 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02015923 2021-03-16

CCRe-IV

Hospital Universitari de Bellvitge

Phase 4 Terminated

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡